Blood transfusion usage among adults with sickle cell disease - a single institution experience over ten years

British Journal of Haematology

Volumn 152, Issue 6, 2011, Pages 766-770

  Drasar, Emma ^a,b   Igbineweka, Norris ^a   Vasavda, Nisha ^a   Free, Matthew ^b   Awogbade, Moji ^b   Allman, Marlene ^b   Mijovic, Aleksandar ^b   Thein, Swee Lay ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Blood transfusion; Iron overload; Sickle cell disease

Indexed keywords

ABDOMINAL DISEASE; ACUTE CHEST SYNDROME; ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; BRONCHOPNEUMONIA; CHOLECYSTITIS; CONTROLLED STUDY; ERYTHROCYTE TRANSFUSION; EXCHANGE BLOOD TRANSFUSION; FEMALE; HEMOGLOBIN SC DISEASE; HUMAN; LIVER DISEASE; MAJOR CLINICAL STUDY; MALE; PAIN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SICKLE CELL ANEMIA; SICKLE CELL BETA THALASSEMIA; STROKE; TREATMENT PLANNING; UNITED KINGDOM; UNIVERSITY HOSPITAL;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANEMIA, SICKLE CELL; BLOOD TRANSFUSION; FEMALE; HUMANS; LONDON; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 79951969177     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08451.x     Document Type: Article

References (16)

1. Adams, R.J. & Brambilla, D. (2005) Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. New England Journal of Medicine, 353, 2769-2778.
2. Adams, R.J., McKie, V.C., Hsu, L., Files, B., Vichinsky, E., Pegelow, C., Abboud, M., Gallagher, D., Kutlar, A., Nichols, F.T., Bonds, D.R. & Brambilla, D. (1998) Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial doppler ultrasonography. New England Journal of Medicine, 339, 5-11.
3. Cappellini, M.D., Porter, J., El-Beshlawy, A., Li, C.K., Seymour, J.F., Elalfy, M., Gattermann, N., Giraudier, S., Lee, J.W., Chan, L.L., Lin, K.H., Rose, C., Taher, A., Thein, S.L., Viprakasit, V., Habr, D., Domokos, G., Roubert, B. & Kattamis, A. (2010) Tailoring iron chelation by iron intake and serum ferritin: the prospective EPIC study of deferasirox in 1744 patients with transfusion-dependent anemias. Haematologica, 95, 557-566.
4. Charache, S., Terrin, M.L., Moore, R.D., Dover, G.J., Barton, F.B., Eckert, S.V., McMahon, R.P. & Bonds, D.R. (1995) Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. New England Journal of Medicine, 332, 1317-1322.
5. Claster, S. & Vichinsky, E.P. (2003) Managing sickle cell disease. BMJ, 327, 1151-1155.
6. Lanzkron, S., Strouse, J.J., Wilson, R., Beach, M.C., Haywood, C., Park, H., Witkop, C., Bass, E.B. & Segal, J.B. (2008) Systematic review: hydroxyurea for the treatment of adults with sickle cell disease. Annals of Internal Medicine, 148, 939-955.
7. Lusher, J.M., Haghighat, H. & Khalifa, A.S. (1976) A prophylactic transfusion program for children with sickle cell anemia complicated by CNS infarction. American Journal of Hematology, 1, 265-273.
8. Miller, S.T., Wright, E., Abboud, M., Berman, B., Files, B., Scher, C.D., Styles, L. & Adams, R.J. (2001) Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia. Journal of Pediatrics, 139, 785-789.
9. Modell, B. & Darlison, M. (2008) Global epidemiology of haemoglobin disorders and derived service indicators. Bulletin of the World Health Organization, 86, 480-487.
10. de Montalembert, M. (2007) Hydroxyurea: benefits and risks in patients affected with sickle cell anemia. In: Hematology Education for 12th Annual Congress of the European Hematology Association, Vol. 1, pp. 148-153. EHA, Vienna, Austria.
11. NHS sickle cell and thalassaemia screening programme (2009) Annual Report for the NHS Sickle Cell and Thalassaemia Screening Programme for the Year 2008/9. p. 33. King's College London School of Medicine, London.
12. Styles, L.A., Abboud, M., Larkin, S., Lo, M. & Kuypers, F.A. (2007) Transfusion prevents acute chest syndrome predicted by elevated secretory phospholipase A2. British Journal Haematology, 136, 343-344.
13. Vichinsky, E.P., Neumayr, L.D., Earles, A.N., Williams, R., Lennette, E.T., Dean, D., Nickerson, B., Orringer, E., McKie, V., Bellevue, R., Daeschner, C. & Manci, E.A. (2000) Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. New England Journal of Medicine, 342, 1855-1865.
14. Wahl, S. & Quirolo, K.C. (2009) Current issues in blood transfusion for sickle cell disease. Current Opinion in Pediatrics, 21, 15-21.
15. Weatherall, D.J. (2010) The inherited diseases of hemoglobin are an emerging global health burden. Blood, 115, 4331-4336.
16. Zimmerman, S.A., Schultz, W.H., Davis, J.S., Pickens, C.V., Mortier, N.A., Howard, T.A. & Ware, R.E. (2004) Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease. Blood, 103, 2039-2045.